CEO of Dendeon Sold 202,090 shares, he's not confident about Dendreon!

[1pennyStock_dot_com]

Here's a fact,

On April 2, 2007. The CEO of Dendreon Corporation sold 202,090 shares
of his own company for $2,720,131 million dollars.

Why is he making this move? I think It usually is a sign that he's
not
confident that the FDA will approve the drug Provenge on May 15th.
He's getting out fast. If a CEO of his own company selling more of
his
shares in the company and not acquiring more, it is a sign that tells
me, he knows more anything else. Because of this information, I've
bought so much Put options on this stock based on the lack of
confidence of Mr. Mitchelle Gold.

Here's the prove.
http://finance.yahoo.com/q/it?s=DNDN

Take a look at the April 2, 2007 on the insider trading list.